-
Je něco špatně v tomto záznamu ?
Direct analysis in real time--high resolution mass spectrometry as a valuable tool for the pharmaceutical drug development
J. Srbek, B. Klejdus, M. Douša, J. Břicháč, P. Stasiak, J. Reitmajer, L. Nováková,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- chromatografie na tenké vrstvě metody MeSH
- hmotnostní spektrometrie metody MeSH
- léčivé přípravky analýza chemie MeSH
- objevování léků * MeSH
- pomocné látky chemie MeSH
- tablety chemie MeSH
- vysokoúčinná kapalinová chromatografie metody MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
In this study, direct analysis in real time-mass spectrometry (DART-MS) was assessed for the analysis of various pharmaceutical formulations with intention to summarize possible applications for the routine pharmaceutical development. As DART is an ambient ionization technique, it allows direct analysis of pharmaceutical samples in solid or liquid form without complex sample preparation, which is often the most time-consuming part of the analytical method. This makes the technique suitable for many application fields, including pharmaceutical drug development. DART mass spectra of more than twenty selected tablets and other common pharmaceutical formulations, i.e. injection solutions, ointments and suppositories developed in the pharmaceutical industry during several recent years are presented. Moreover, as thin-layer chromatography (TLC) is still very popular for the monitoring of the reactions in the synthetic chemistry, several substances were analyzed directly from the TLC plates to demonstrate the simplicity of the technique. Pure substance solutions were spotted onto a TLC plate and then analyzed with DART without separation. This was the first DART-MS study of pharmaceutical dosage forms using DART-Orbitrap combination. The duration of sample analysis by the DART-MS technique lasted several seconds, allowing enough time to collect sufficient number of data points for compound identification. The experimental setup provided excellent mass accuracy and high resolution of the mass spectra which allowed unambiguous identification of the compounds of interest. Finally, DART mass spectrometry was also used for the monitoring of the selected impurity distribution in the atorvastatin tablets. These measurements demonstrated DART to be robust ionization technique, which provided easy-to-interpret mass spectra for the broad range of compounds. DART has high-throughput potential for various types of pharmaceutical analyses and therefore eliminates the time for sample cleanup and chromatographic separation.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15023089
- 003
- CZ-PrNML
- 005
- 20150709122415.0
- 007
- ta
- 008
- 150709s2014 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.talanta.2014.07.007 $2 doi
- 035 __
- $a (PubMed)25159441
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Srbek, Jan $u Zentiva, k.s. Praha, A Sanofi Company, U Kabelovny 130, 102 37 Praha 10, Czech Republic. Electronic address: jan.srbek@zentiva.cz.
- 245 10
- $a Direct analysis in real time--high resolution mass spectrometry as a valuable tool for the pharmaceutical drug development / $c J. Srbek, B. Klejdus, M. Douša, J. Břicháč, P. Stasiak, J. Reitmajer, L. Nováková,
- 520 9_
- $a In this study, direct analysis in real time-mass spectrometry (DART-MS) was assessed for the analysis of various pharmaceutical formulations with intention to summarize possible applications for the routine pharmaceutical development. As DART is an ambient ionization technique, it allows direct analysis of pharmaceutical samples in solid or liquid form without complex sample preparation, which is often the most time-consuming part of the analytical method. This makes the technique suitable for many application fields, including pharmaceutical drug development. DART mass spectra of more than twenty selected tablets and other common pharmaceutical formulations, i.e. injection solutions, ointments and suppositories developed in the pharmaceutical industry during several recent years are presented. Moreover, as thin-layer chromatography (TLC) is still very popular for the monitoring of the reactions in the synthetic chemistry, several substances were analyzed directly from the TLC plates to demonstrate the simplicity of the technique. Pure substance solutions were spotted onto a TLC plate and then analyzed with DART without separation. This was the first DART-MS study of pharmaceutical dosage forms using DART-Orbitrap combination. The duration of sample analysis by the DART-MS technique lasted several seconds, allowing enough time to collect sufficient number of data points for compound identification. The experimental setup provided excellent mass accuracy and high resolution of the mass spectra which allowed unambiguous identification of the compounds of interest. Finally, DART mass spectrometry was also used for the monitoring of the selected impurity distribution in the atorvastatin tablets. These measurements demonstrated DART to be robust ionization technique, which provided easy-to-interpret mass spectra for the broad range of compounds. DART has high-throughput potential for various types of pharmaceutical analyses and therefore eliminates the time for sample cleanup and chromatographic separation.
- 650 _2
- $a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
- 650 _2
- $a chromatografie na tenké vrstvě $x metody $7 D002855
- 650 12
- $a objevování léků $7 D055808
- 650 _2
- $a pomocné látky $x chemie $7 D005079
- 650 _2
- $a hmotnostní spektrometrie $x metody $7 D013058
- 650 _2
- $a léčivé přípravky $x analýza $x chemie $7 D004364
- 650 _2
- $a tablety $x chemie $7 D013607
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Klejdus, Bořivoj $u Institute of Chemistry and Biochemistry, Faculty of Agronomy, Mendel University in Brno, Zemědělská 1, 613 00 Brno, Czech Republic; CEITEC - Central European Institute of Technology, Mendel University in Brno, Zemědělská 1, 613 00 Brno, Czech Republic.
- 700 1_
- $a Douša, Michal $u Zentiva, k.s. Praha, A Sanofi Company, U Kabelovny 130, 102 37 Praha 10, Czech Republic. Electronic address: michal.dousa@seznam.cz.
- 700 1_
- $a Břicháč, Jiří $u Zentiva, k.s. Praha, A Sanofi Company, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
- 700 1_
- $a Stasiak, Pawel $u Zentiva, k.s. Praha, A Sanofi Company, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
- 700 1_
- $a Reitmajer, Josef $u Zentiva, k.s. Praha, A Sanofi Company, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
- 700 1_
- $a Nováková, Lucie $u Department of Analytical Chemistry, Charles University, Faculty of Pharmacy, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
- 773 0_
- $w MED00004484 $t Talanta $x 1873-3573 $g Roč. 130, č. - (2014), s. 518-26
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25159441 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20150709122434 $b ABA008
- 999 __
- $a ok $b bmc $g 1083427 $s 906082
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 130 $c - $d 518-26 $i 1873-3573 $m Talanta $n Talanta $x MED00004484
- LZP __
- $a Pubmed-20150709